Longitudinal changes in bone and mineral metabolism after cessation of cinacalcet in dialysis patients with secondary hyperparathyroidism

BACKGROUND: The calcimimetic agent cinacalcet is effective for the management of secondary hyperparathyroidism (SHPT) in dialysis patients. Changes to reimbursement of cinacalcet in Australia provided an opportunity to assess effects of medication cessation on biochemical and clinical outcomes in di...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruderman, Irene, Smith, Edward R., Toussaint, Nigel D., Hewitson, Tim D., Holt, Stephen G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952622/
https://www.ncbi.nlm.nih.gov/pubmed/29764395
http://dx.doi.org/10.1186/s12882-018-0910-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952622/
https://www.ncbi.nlm.nih.gov/pubmed/29764395
http://dx.doi.org/10.1186/s12882-018-0910-9

Ejemplares similares